DR. MANISH DHAWAN, MD

Plain English
This study looked at a new treatment approach for patients with advanced prostate cancer that has not spread beyond control by hormone therapy. Researchers tested a combination of two drugs, cabazitaxel and carboplatin, followed by abiraterone, and found that 84.6% of participants did not see any worsening of their cancer after 12 months. Additionally, 66.7% had very low levels of prostate-specific antigen (PSA), indicating a strong response to the treatment. Who this helps: This helps patients with high-volume metastatic prostate cancer.

Plain English
This research study focuses on improving the reliability of software development processes, specifically Continuous Integration and Continuous Delivery (CI/CD) pipelines, by using artificial intelligence (AI). It found that existing pipelines often face significant issues, such as flaky tests and noisy builds, resulting in failure rates of 11-27% for tests and 5-16% for builds. The new AI framework introduced in the study could lead to up to a 60% reduction in failures caused by flaky tests and a 50-80% decrease in time taken to get feedback on code changes, making software delivery faster and more efficient. Who this helps: This benefits software development teams and companies that rely on timely and reliable software updates.

Plain English
This study looked at how food and the type of pill affect how well the cancer drug migoprotafib works in patients. Researchers found that taking migoprotafib as a tablet instead of a capsule had very little difference in absorption, but eating a high-fat meal before taking the drug significantly reduced its peak concentration in the bloodstream. These results help doctors determine the best way to prescribe migoprotafib for patients with advanced solid tumors. Who this helps: This helps cancer patients taking migoprotafib.

Plain English
This study looked at how using peer navigators—people with similar experiences—can help improve participation rates in research about babies exposed to opioids. After adding peer navigators, the percentage of mothers who agreed to participate increased from 29% to 38%, and the number who were not interested in sharing information dropped from 41% to 26%. This matters because it shows that peer support can lead to better engagement in important health research, especially in vulnerable populations. Who this helps: This helps patients and their families by encouraging more participation in research that can improve care.

Plain English
This study looked at how to effectively launch a research project focusing on infants exposed to opioids during pregnancy while adapting to challenges created by the COVID-19 pandemic. The researchers successfully recruited participants by using virtual methods, with only 5% of mothers of opioid-exposed infants and 8% of mothers of control infants declining to participate due to concerns about MRI scans. Out of 310 enrolled infants, 234 returned for their follow-up visits at six months, indicating strong retention rates. Who this helps: This research benefits pregnant women, infants at risk of opioid exposure, and healthcare providers working with these families.

Plain English
This study looked at how to improve the process of getting consent from caregivers of infants whose mothers used opioids during pregnancy while also including caregivers of infants who were not exposed. Researchers created a digital tool, an 11-minute video with diverse avatars, to help explain the study and found that 95% of participants understood its purpose. More caregivers of infants exposed to opioids decided to enroll in the study (89%) compared to those with unexposed infants (51%), highlighting the effectiveness of this interactive tool for communication. Who this helps: This benefits caregivers of infants affected by prenatal opioid exposure and the researchers studying their outcomes.

Plain English
This research paper focuses on how B cells, a type of immune cell, respond to the COVID-19 virus and its changing variants. The study found that B cells can develop into memory cells that help protect against future infections, and when these cells don’t work properly, it can worsen COVID-19 symptoms and make vaccines less effective. Understanding this process is important for creating better vaccines and treatments for COVID-19. Who this helps: This benefits patients and vaccine developers.

Plain English
This study looked at how different target levels of oxygen in the blood affect infants with bronchopulmonary dysplasia (BPD), a lung condition often seen in premature babies. Researchers compared two groups: one aimed for higher oxygen levels (96% or more) and the other for lower levels (90-94%). They found that both groups had similar rates of low oxygen events, but infants in the lower oxygen group tended to stay in the hospital longer (average 48 weeks compared to 45 weeks for the higher group). This research helps understand how to manage oxygen levels in these vulnerable infants, potentially leading to better treatment strategies. Who this helps: This helps healthcare providers treating premature infants with BPD.

Plain English
This study looked at how a substance called PolySTAT affects blood clots. Researchers found that when blood clots were treated with PolySTAT, they contracted more quickly and strongly, which is important for stopping bleeding. Specifically, PolySTAT increased the forces generated by platelets during clotting, making the clots stiffer and more resilient. This is crucial because faster and stronger clot contraction can lead to better recovery from severe bleeding. Who this helps: This benefits patients experiencing severe bleeding or undergoing surgeries where blood loss is a concern.

Plain English
This study looked at patients who had complicated airway surgeries while being supported by a specialized machine called extracorporeal membrane oxygenation (ECMO) between January 2023 and May 2024. The research highlighted four specific cases where ECMO was crucial in helping patients with major airway issues, ensuring they could breathe properly during surgery and improving their overall recovery. By demonstrating the effectiveness of using ECMO in these situations, the study underscores its importance in making difficult surgeries safer and more successful. Who this helps: This helps patients undergoing complex airway surgeries and their doctors.

Plain English
This study looked at how patients with advanced prostate cancer and specific genetic mutations were treated and what their outcomes were. Researchers reviewed the medical records of 138 patients and found that the most common mutations were CDK12, BRCA2, and ATM. Patients had a median survival of about 36 months after starting their first treatment, but survival rates decreased with later treatments, showing a need for better strategies as the disease progresses. Who this helps: This benefits patients with metastatic prostate cancer and their doctors by providing insights into treatment effectiveness based on genetic factors.

Plain English
This study looked at the effectiveness and safety of a new drug called Debio 1347 in patients with advanced solid tumors that have specific genetic changes known as FGFR fusions. Out of 63 patients treated, only 3 (or 5%) showed some improvement, while 26 (or 45%) experienced stable disease for at least six weeks. Although the drug had manageable side effects, the low effectiveness means it is unlikely to help these patients in the future. Who this helps: This helps patients with FGFR fusion-positive advanced solid tumors.

Plain English
This study looked at two treatments for serious bleeding in the upper gastrointestinal tract in patients taking blood thinners. It found that while both mechanical therapy (using clips) and thermal therapy were equally effective in stopping the bleeding, those treated with mechanical therapy faced longer hospital stays (61.2% vs 38.9%), more serious complications (56% vs 37.5%), and higher rates of needing intensive care (50% vs 20.8%). This matters because it helps doctors choose the safer option for patients experiencing this type of bleeding. Who this helps: Patients with upper gastrointestinal bleeding who are on blood thinners.

Plain English
This study looked at how well doctors and nurses in an intensive care unit (ICU) understood and used central line bundles, which are practices designed to prevent infections from central lines. Researchers found that the average knowledge score was 82%, with those trained in these practices scoring higher. The results highlight that training boosts awareness and adherence to these protocols, potentially reducing infection rates in patients. Who this helps: This helps patients in ICUs by reducing the risk of bloodstream infections.

Plain English
This study looked at how artificial intelligence (AI) is being used in dentistry to analyze images and help with clinical decision-making. Out of over 1,300 articles reviewed, 276 were found to be relevant, using a total of 601,122 dental images. The research revealed that AI, particularly through techniques like convolutional neural networks, is helping dentists make better diagnoses and treatment decisions, especially in areas like oral surgery and orthodontics. Who this helps: This helps dentists improve patient care and outcomes.

Plain English
This research looked at the effectiveness of topical hemostatic agents (THAs) in controlling bleeding from tumors in the gastrointestinal (GI) tract. The study found that THAs successfully stopped bleeding in 94.1% of cases, but early or delayed rebleeding occurred in about 13.9% and 11.4% of patients, respectively. This is significant because traditional treatments often struggle with such bleeding, and THAs offer a promising alternative. Who this helps: Patients with cancer-related GI bleeding.

Plain English
This study looked at a new way to provide genetic testing for men with prostate cancer using a system called the Genetic Testing Station (GTS). Out of 713 men referred to this program, 592 (83%) completed the genetic tests, with those using the GTS having much higher completion rates compared to previous methods. However, the research also found that Black men were less likely to complete the testing compared to White men, highlighting ongoing racial disparities in healthcare access. Who this helps: This helps patients, particularly men with prostate cancer seeking genetic testing, and healthcare providers looking to improve testing access and equity.

Plain English
This study looked at how T cells, a crucial part of the immune system, respond to the SARS-CoV-2 virus, which causes COVID-19. The researchers found that T cells are important for controlling the virus and protecting against severe illness, but issues like overactive T cells can lead to serious complications such as acute respiratory distress syndrome (ARDS). Understanding these mechanisms is essential for improving COVID-19 vaccines and treatments, especially as new variants emerge. Who this helps: This benefits patients and healthcare providers by informing better treatment and vaccination strategies against COVID-19.

Plain English
This study looked at a new method called EDGE for accessing the pancreas and bile ducts in patients who have had a specific type of stomach surgery (Roux-en-Y gastric bypass). The research found that EDGE was highly effective, with a success rate of 96% for technical success and 91% for clinical success, while experiencing some side effects in about 17% of cases. This matters because EDGE could offer a safer and faster alternative to current methods, helping patients recover more quickly and reducing hospital stays. Who this helps: Patients who have had Roux-en-Y gastric bypass and need treatment for pancreatic or bile duct issues.

Plain English
This study looked at acute kidney injury (AKI) in patients who were not infected with COVID-19 but were treated in intensive care units during the pandemic. Out of 200 patients studied, 42% died within 30 days, and factors like age over 60, infections, and pre-existing liver issues significantly increased the risk of death. These findings highlight that the pandemic affected the types and outcomes of kidney injuries, with more patients suffering from AKI due to infections instead of post-surgery complications. Who this helps: This research benefits doctors and healthcare providers working with critically ill patients.

Plain English
This study looked at how emerging variants of the COVID-19 virus, particularly the Omicron variant, affect the effectiveness of existing vaccines, especially for people with weakened immune systems. The researchers found that the immune response from vaccines decreases over time, and vaccinated individuals can still experience breakthrough infections. They also noted that different variants show varying levels of resistance to vaccine-induced antibodies, highlighting the need for new strategies to enhance vaccine effectiveness against these variants. Who this helps: This research benefits patients, especially those who are immunocompromised, by informing strategies to improve vaccine responses.

Plain English
This study looked at a specific type of immune cell called regulatory T cells (Tregs) in COVID-19 patients, particularly those suffering from long COVID. It found that COVID-19 patients have significantly fewer Tregs than healthy individuals, which may worsen inflammation, increase the risk of respiratory failure, and raise the chances of developing long COVID. Understanding how Tregs behave in these patients can help develop new treatments to improve recovery and manage symptoms. Who this helps: This benefits patients recovering from COVID-19, particularly those dealing with long COVID.

Plain English
This study looked at whether specific features of ovarian tumors could help predict if mutations in the BRCA1 and BRCA2 genes are harmful. After analyzing data from over 10,000 cases of ovarian cancer, researchers found that no specific tumor type clearly indicated if a BRCA mutation was dangerous. However, they did find that certain histologies, like mucinous and clear cell tumors, hinted against the mutations being harmful. This research is important because it can help doctors better classify BRCA variants and manage treatment for patients with ovarian cancer. Who this helps: Patients with ovarian cancer and genetic BRCA testing.

Plain English
This study looked at the side effects caused by combined immune checkpoint inhibitors, which are treatments for cancer that can affect the gastrointestinal system. The analysis included data from 53 trials with a total of 6,581 patients and found that about 25.4% of patients experienced diarrhea, nearly 13% had liver inflammation (hepatitis), and almost 7.5% suffered from inflammation of the pancreas (pancreatitis). This research is important because it highlights the frequency of serious gastrointestinal side effects from these cancer treatments, indicating a need for more investigation into how these issues affect patient care and treatment success. Who this helps: This benefits cancer patients receiving immune checkpoint inhibitor therapy.

Plain English
This study looked at how to manage lung inflammation in COVID-19, particularly when severe variants like Delta and Omicron are involved. Researchers found that COVID-19 can trigger a "cytokine storm," where the body's immune response goes into overdrive, causing lung damage and serious breathing issues. While new treatments are being tested to reduce this inflammation, they must be used carefully to avoid making patients more vulnerable to infections. Who this helps: This helps COVID-19 patients and healthcare providers by exploring better treatment options.

Plain English
This research focuses on nanovaccines, which use tiny particles to enhance our immune responses against infectious diseases. Researchers found that these nanovaccines can boost immunity quickly and effectively while reducing side effects. They have the potential for targeted delivery and longer-lasting protection, making them promising for future vaccines, especially in areas like cancer treatment and infectious disease prevention. Who this helps: This benefits patients by providing more effective and safer vaccination options.

Plain English
This study reviewed different types of coronaviruses, focusing on how SARS-CoV-2, which causes COVID-19, is similar to earlier strains like SARS-CoV-1 and MERS-CoV. Researchers found that SARS-CoV-2 is particularly good at attaching to human cells and evading the immune response, which can lead to severe health issues like lung failure and increased death rates. This information is important as it helps guide future research and public health responses to prevent and treat COVID-19 and other viral diseases. Who this helps: This helps patients, healthcare workers, and public health officials.

Plain English
This study looked at how small molecules called microRNAs (miRNAs) could be used to create new treatments for COVID-19. It found that miRNAs play an important role in fighting the virus by managing ACE2 receptors, which can influence how severe an infection is. Effective use of these miRNAs could reduce the amount of virus in the body and lessen harmful immune responses, making it crucial for future treatment development. Who this helps: This helps patients suffering from COVID-19 and healthcare providers looking for better treatment options.

Plain English
This research paper examines the challenges and opportunities for improving vaccine and medicine production in Africa, where diseases like malaria and tuberculosis significantly impact health. Currently, Africa imports 99% of its medicines and 95% of its vaccines, which became evident during the COVID-19 pandemic when the continent struggled to secure enough supplies. Strengthening local manufacturing could help Africa better respond to health crises and reduce reliance on imports. Who this helps: This benefits African patients and healthcare systems by ensuring better access to essential medicines and vaccines.

Plain English
This study looked at how natural products, like herbal treatments, can help fight COVID-19 by targeting the virus that causes it, known as SARS-CoV-2. The researchers found that certain natural extracts can prevent the virus from entering human cells and stop it from replicating, which is crucial for reducing the severity of infection. This is important because it highlights the potential of using traditional medicines alongside regular treatments to improve patient care and develop new antiviral drugs. Who this helps: This helps patients with COVID-19 and healthcare providers looking for effective treatment options.

Plain English
This study looked at new ways to find potential treatments for COVID-19, particularly focusing on strategies that identify effective drugs through computer analysis and molecular interactions. Researchers found that various compounds may be able to help stop the virus, although no specific treatment has been proven effective yet. This is important because, as of now, COVID-19 treatment mainly relieves symptoms rather than curing the illness, making these new discoveries crucial in the ongoing fight against the pandemic. Who this helps: This helps patients and healthcare providers searching for better treatments for COVID-19.

Plain English
This research reviews the Hepatitis E virus (HEV), a serious health issue that can cause liver infections and is spread through contaminated water or food. The study highlights high infection rates in pigs, with a notable risk of HEV contamination in our water and food supply, posing a threat to human health. It emphasizes the need to investigate the connections between pig farming and the potential for HEV to spread in both communities and food chains. Who this helps: This benefits public health officials and livestock farmers who work to ensure food safety.

Plain English
Researchers studied the Omicron variant of the COVID-19 virus, which has many mutations making it more contagious and better at evading vaccines. They found that Omicron quickly became the dominant strain in places like the UK and South Africa, posing a significant risk of outbreaks even among vaccinated individuals due to its ability to spread easily. This research is important because it helps us understand how the Omicron variant works and what can be done to prevent future COVID-19 surges. Who this helps: This helps patients, public health officials, and vaccine developers.

Plain English
This study explored how certain genetic variations, called copy number variants (CNVs), affect the risk of breast cancer in people with harmful BRCA1 or BRCA2 genes. Researchers examined over 26,000 individuals and found that having a deletion in BRCA1 increased the risk of breast cancer by 21%, while a deletion in another gene, SULT1A1, actually decreased the risk by 27% in BRCA1 carriers. Understanding these variations is essential because they help explain why some people with BRCA mutations develop cancer while others do not. Who this helps: This information benefits patients with BRCA mutations and their healthcare providers by identifying factors that influence their cancer risk.

Plain English
This paper explored how carotenoids, natural pigments found in fruits and vegetables, can help prevent and treat respiratory diseases like asthma, lung cancer, and COPD. The research highlighted that eating more carotenoids can lower the risk of these chronic diseases and enhance overall lung health, with recent studies showing promising results in managing inflammation in the respiratory system. Understanding how carotenoids work could lead to new treatments and better health outcomes for people with respiratory conditions. Who this helps: This helps patients with respiratory diseases and healthcare providers looking for effective dietary interventions.

Plain English
This research paper reviews monkeypox, a disease that can spread from animals to humans, and has recently spread to over 90 countries outside Africa. It highlights that most cases are now in men in their thirties, mostly due to close or sexual contact with infected individuals. While there are no specific treatments for monkeypox, some existing medications and vaccines used for smallpox may be helpful in treating it. Who this helps: This information benefits patients and healthcare providers dealing with monkeypox outbreaks.

Plain English
This study looks at the disease leishmaniasis, which is spread by sandfly bites and affects about 58,500 people each year, resulting in a mortality rate of nearly 7%. The researchers explore how new advanced methods, known as omics, can help identify targets for developing better drugs and vaccines, especially in light of the challenges posed by drug resistance. Using a combination of genetic and protein data, they aim to create more effective treatments for this serious disease. Who this helps: This research benefits patients suffering from leishmaniasis and the doctors treating them.

Plain English
This study looked at a serious complication called cavernous sinus syndrome (CSS) that can occur in patients with a fungal infection linked to COVID-19, known as rhino-orbito-cerebral mucormycosis. Out of the patients studied, 28% experienced CSS, and those with this syndrome showed more severe symptoms and a higher need for surgery. The findings, which included a 13% to 27% mortality rate in the CSS group within 8 to 24 weeks, emphasize the importance of better diagnostic tools for identifying this condition early. Who this helps: This research benefits doctors and healthcare providers managing COVID-19 patients at risk of serious fungal infections.